Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy.
about
Inflammation in HIV-infected patients: impact of HIV, lifestyle, body composition, and demography - a cross sectional cohort studyDual energy X-Ray absorptiometry body composition reference values from NHANESAdipokines, hormones related to body composition, and insulin resistance in HIV fat redistribution syndrome.Carotid intima media thickness is associated with body fat abnormalities in HIV-infected patientsThe development of simple anthropometric measures to diagnose antiretroviral therapy-associated lipodystrophy in resource limited settingsLipodystrophy defined by Fat Mass Ratio in HIV-infected patients is associated with a high prevalence of glucose disturbances and insulin resistance.Early loss of bone mineral density is correlated with a gain of fat mass in patients starting a protease inhibitor containing regimen: the prospective Lipotrip study.Effects of switching from stavudine to raltegravir on subcutaneous adipose tissue in HIV-infected patients with HIV/HAART-associated lipodystrophy syndrome (HALS). A clinical and molecular studyNew and emerging agents in the management of lipodystrophy in HIV-infected patients.Characteristics of body fat, body fat percentage and other body composition for Koreans from KNHANES IV.Body composition study by dual-energy x-ray absorptiometry in familial partial lipodystrophy: finding new tools for an objective evaluationHip bone geometry in HIV/HCV-co-infected men and healthy controls.Hepatic steatosis associated with increased central body fat by dual-energy X-ray absorptiometry and uncontrolled HIV in HIV/hepatitis C co-infected persons.Multiple frequency bioimpedance is an adequate tool to assess total and regional fat mass in HIV-positive patients but not to diagnose HIV-associated lipoatrophy: a pilot studyFrom old to new nucleoside reverse transcriptase inhibitors: changes in body fat composition, metabolic parameters and mitochondrial toxicity after the switch from thymidine analogs to tenofovir or abacavir.Adipose Tissue in HIV Infection.IL-4 and IL-6 levels and adipose tissue distribution in HIV-1 patients under antiretroviral therapy.Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio.Social isolation in HIV-infected patients according to subjective patient assessment and DEXA-confirmed severity of lipodystrophy.Trunk and lower limb fat mass evaluated by dual-energy X-ray absorptiometry in a 20- to 80-year-old healthy Italian population.Accuracy and concordance of anthropometry for measuring regional fat distribution in adults aged 20-55 years.Effects of discontinuing stavudine or protease inhibitor therapy on human immunodeficiency virus-related fat redistribution evaluated by dual-energy x-ray absorptiometry.A prospective study of body fat redistribution, lipid, and glucose parameters in HIV-infected patients initiating combination antiretroviral therapy.Central/Peripheral fat mass ratio is associated with increased risk of hypertension in HIV-infected patients.Visceral adipose tissue and carotid intima-media thickness in HIV-infected patients undergoing cART: a prospective cohort study.Surrogate markers of visceral adipose tissue in treated HIV-infected patients: accuracy of waist circumference determination.Body fat redistribution and changes in lipid and glucose metabolism in people living with HIV/AIDS.Proposed ratios and cutoffs for the assessment of lipodystrophy in HIV-seropositive individuals.Diabetes mellitus in HIV-infected patients: fasting glucose, A1c, or oral glucose tolerance test - which method to choose for the diagnosis?Lipodystrophy diagnosis in people living with HIV/AIDS: prediction and validation of sex-specific anthropometric models.
P2860
Q28484274-D8C7AD94-0AF2-4285-9557-BA5C1507E2BBQ33503221-B367E385-715C-416B-A38F-7F48E083CC69Q33836736-ACEE516C-9B6A-485C-833A-78E0F9D09787Q33864945-F8055944-00EF-4DAE-B780-6BE6B1575D81Q34067682-698943BB-4E6F-473D-A2E9-B449C492CBD1Q34367498-EC04E693-D108-4AE9-84F2-2B57B728F7DDQ34786514-4E191138-CF00-4B98-8036-685335C0EE34Q35106654-7A1B980A-EDB9-4B45-B003-2C537E5BAF3CQ35557229-8C303245-B20D-494D-A8F2-173E59FCAFDFQ35590635-0EED410B-10F1-41F6-B5BF-A01881332225Q36474010-BCBE67CE-7508-4599-91A7-75ADB8E88C04Q36600009-D2C5D028-CCC7-45DA-80C7-53629075A669Q37238258-2EAE698E-DFD9-4B70-986D-FE0B0D46D897Q37419698-EFE71C20-3EDD-4F0B-B23E-C3612318932FQ37828539-94C68B14-CAA9-4AE4-AAC6-11401077D977Q40038736-A7F1D45C-52E9-4A68-A951-9F531DD54648Q41461481-ADFB2203-42B7-4441-9D4E-99AA10162DBEQ41605464-CC77303E-F9AB-4594-9E20-FF4EFC949204Q42263948-A9D4799C-BB0A-4E02-BE37-A0E570542C7CQ43577021-F0CD0A9B-9C54-4653-95D9-5F12100B3F73Q44664801-222FFF8E-1409-4B6C-B5AF-2AF0C8335287Q45419995-8EED69EA-2F97-4BBA-A87D-F7C3DA07AC0DQ46269347-4C29FDF5-8B88-466F-9C11-F9076E6E056AQ47190529-C3B1B128-C603-48C9-95FF-896FE351881CQ48043453-E395A392-38C8-4520-ADBB-9226C4FD93A4Q51153029-4516763E-5BFE-40F8-94E2-C72CD936BA1FQ51251254-902DD086-383C-4EBE-89F1-82063BFE6CFAQ51318101-B04D500C-7047-4FE8-8A17-A2BCB380664EQ55510378-251214B8-DA0B-40B6-978C-AD8C4A424171Q55513048-923F9B5D-339C-4874-85DE-83193F918A12
P2860
Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Total body composition by DXA ...... es for defining lipodystrophy.
@en
type
label
Total body composition by DXA ...... es for defining lipodystrophy.
@en
prefLabel
Total body composition by DXA ...... es for defining lipodystrophy.
@en
P2093
P356
P1476
Total body composition by DXA ...... es for defining lipodystrophy.
@en
P2093
Aquilina C
Delpierre C
Marion-Latard F
P304
P356
10.1385/JCD:8:3:287
P577
2005-01-01T00:00:00Z